<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCM</journal-id>
<journal-id journal-id-type="hwp">spjcm</journal-id>
<journal-title>Journal of Composite Materials</journal-title>
<issn pub-type="ppub">0021-9983</issn>
<issn pub-type="epub">1530-793X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0021998311426020</article-id>
<article-id pub-id-type="publisher-id">10.1177_0021998311426020</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fabrication and characterization of triple nanobioceramic composite foam</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ghomi</surname><given-names>H</given-names></name>
<xref ref-type="corresp" rid="corresp1-0021998311426020"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fathi</surname><given-names>MH</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Edris</surname><given-names>H</given-names></name>
</contrib>
</contrib-group>
<aff id="aff1-0021998311426020">Biomaterials Group, Department of Materials Engineering, Isfahan University of Technology, Isfahan, Iran</aff>
<author-notes>
<corresp id="corresp1-0021998311426020">H Ghomi, Biomaterials Group, Department of Materials Engineering, Isfahan University of Technology, Isfahan, 8415683111, Iran Email: <email>h.ghomi@ma.iut.ac.ir</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>46</volume>
<issue>15</issue>
<fpage>1809</fpage>
<lpage>1817</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012 Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>In this study, triple nanobioceramic composite foam consisting of bioactive glass (BG), forsterite, and hydroxyapatite (HA) with highly porous structure and high mechanical strength was successfully fabricated via gelcasting method. The BG and forsterite were added to HA as second-phase ceramics to enhance simultaneously its bioactivity, biodegradability, and mechanical properties. The prepared foams have a crystallite size in the range 30–52 nm (while the crystallite size of initial HA and forsterite powders is about 22 nm), pore size in the range 100–300 µm, and total and interconnected porosity upto 87% and 81%, respectively. The compressive strength measurements showed that the foams have an excellent compressive strength (2.19–3.68 MPa), which is appropriate for load-bearing tissue engineering applications and is close to the compressive strength of spongy bone. In vitro tests proved the good bioactivity and resorbability of the foams. The resulting composite foams have similar chemical composition to the mineral phase of bone and it is possible to optimize the ratio of BG phase to ceramic phases for achieving appropriate mechanical strength, bioactivity, and biodegradability level needed for different applications.</p>
</abstract>
<kwd-group>
<kwd>Sol-gel processes</kwd>
<kwd>gelcasting</kwd>
<kwd>nanocomposites</kwd>
<kwd>porosity</kwd>
<kwd>mechanical properties</kwd>
<kwd>biomedical applications</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0021998311426020" sec-type="intro"><title>Introduction</title>
<p>The third generation of biomaterials is expected to be degradable and bioactive porous scaffolds to enhance the body’s own regenerative capacity by stimulating genes, which initiate repair at the site of damage or disease.<sup><xref ref-type="bibr" rid="bibr1-0021998311426020">1</xref></sup> It was demonstrated that an ideal scaffold should have good mechanical properties and be biodegradable, as well as appropriate pore size and porosity, which can match with the growth of cells and bone tissue. The ideal candidate material for an ideal scaffold would combine controlled resorbability and bioactivity.<sup><xref ref-type="bibr" rid="bibr2-0021998311426020">2</xref>,<xref ref-type="bibr" rid="bibr3-0021998311426020">3</xref></sup></p>
<p>Hydroxyapatite (HA; Ca<sub>10</sub>(PO<sub>4</sub>)<sub>6</sub>(OH)<sub>2</sub>) bioceramic has been found to bond with living bone tissue through a bone-like apatite layer. The HA, being chemically similar to the inorganic constituent of natural bone and owing to its excellent biocompatibility and osteoconductivity, has been studied extensively as a bone replacement. However, the clinical use of HA is limited by its inferior mechanical properties (especially fracture toughness), also by its high crystallinity since bone mineral is only poorly crystallized nanoapatite crystals. To extend the areas of application of HA, many researchers have tried to improve its strength and fracture toughness by producing HA-based bioceramic composites in various systems.<sup><xref ref-type="bibr" rid="bibr4-0021998311426020">4</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr10-0021998311426020">10</xref></sup> The HA and their composites are potential implant materials particularly for hard tissue replacement application.<sup><xref ref-type="bibr" rid="bibr11-0021998311426020">11</xref></sup> Hence, additions of second-phase bioceramic materials to the HA matrix to obtain products with improved strength and toughness has been an interesting subject matter of research in recent years.<sup><xref ref-type="bibr" rid="bibr12-0021998311426020">12</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr15-0021998311426020">15</xref></sup></p>
<p>Forsterite (Mg<sub>2</sub>SiO<sub>4</sub>) is a novel bioceramic in the magnesia–silica system with high mechanical properties, good biocompatibility, and considerable fracture toughness (K<sub>IC</sub> = 2.4 MPa m<sup>1/2</sup>, superior to the lower limit reported for cortical bone) in comparison to HA ceramics (0.6–1.0 MPa m<sup>1/2</sup>).<sup><xref ref-type="bibr" rid="bibr16-0021998311426020">16</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr20-0021998311426020">20</xref></sup> However, the degradation rate of forsterite ceramic is extremely low, and the apatite-formation ability is poor.<sup><xref ref-type="bibr" rid="bibr20-0021998311426020">20</xref></sup> On the other hand, bioactive glasses (BGs) are Class A bioactive materials, which can bond to both hard and soft tissue and can stimulate new bone growth.<sup><xref ref-type="bibr" rid="bibr1-0021998311426020">1</xref></sup> The bone-bonding ability of the BGs has been attributed to their capability to form a surface layer of hydroxyl carbonate apatite in contact with body fluid.<sup><xref ref-type="bibr" rid="bibr7-0021998311426020">7</xref>,<xref ref-type="bibr" rid="bibr21-0021998311426020">21</xref>,<xref ref-type="bibr" rid="bibr22-0021998311426020">22</xref></sup></p>
<p>In our previous work, bioceramic foams consisting of 100 weight percent (wt.%) forsterite and 100 wt.% HA were prepared via gelcasting method.<sup><xref ref-type="bibr" rid="bibr23-0021998311426020">23</xref>,<xref ref-type="bibr" rid="bibr24-0021998311426020">24</xref></sup> In this study, BG and forsterite were added to HA as second-phase ceramics to enhance simultaneously its bioactivity, biodegradability, and mechanical properties, and composite foam consisting of HA, BG, and forsterite was fabricated by the gelcasting method.</p>
</sec>
<sec id="sec2-0021998311426020" sec-type="methods"><title>Experimental procedure</title>
<sec id="sec3-0021998311426020"><title>Starting materials</title>
<p>In this study, calcium nitrate tetrahydrate (Ca(NO<sub>3</sub>)<sub>2</sub>·4H<sub>2</sub>O, Merck), phosphoric pentoxide (P<sub>2</sub>O<sub>5</sub>, Merck), magnesium carbonate (MgCO<sub>3</sub>, Aldrich, 98% purity), talc (Mg<sub>3</sub>Si<sub>4</sub>O<sub>10</sub>(OH)<sub>2</sub>, Merck, 98% purity), triethyl phosphate (TEP, Aldrich), tetraethyl orthosilicate (TEOS, Merck), hydrochloric acid (HCl, Merck), and absolute ethanol (C<sub>2</sub>H<sub>5</sub>OH, Merck) were used as HA, forsterite, and BG precursors. Gelcasting method components were agarose powder (Merck) as a gelling agent, Tergitol (Aldrich) as a surfactant, and tripolyphosphate sodium (TPP) as a dispersant.</p>
<p>Sodium hydrogen carbonate (NaHCO<sub>3</sub>), sodium chloride (NaCl), potassium chloride (KCl), dipotassium hydrogen phosphate trihydrate (K<sub>2</sub>HPO<sub>4</sub>.3H<sub>2</sub>O), calcium chloride (CaCl<sub>2</sub>), magnesium chloride hexahydrate (MgCl<sub>2</sub>.6H<sub>2</sub>O), sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>), tris-hydroxymethyl aminomethane (HOCH<sub>2</sub>)<sub>3</sub>CNH<sub>2</sub>), and hydrochloric acid (HCl), all from Merck company, were the chemical materials used for preparing the simulated body fluid (SBF).</p>
<p>HA, forsterite, and BG nanopowders were prepared based on the procedures used and reported before at theBiomaterials Group, Department of Materials Engineering, Isfahan University of Technology.<sup><xref ref-type="bibr" rid="bibr25-0021998311426020">25</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr27-0021998311426020">27</xref></sup></p>
</sec>
<sec id="sec4-0021998311426020"><title>Preparation of HA nanopowder</title>
<p>P<sub>2</sub>O<sub>5</sub> and Ca(NO<sub>3</sub>)<sub>2</sub>·4H<sub>2</sub>O with the molar ratio of 0.3 were dissolved in absolute ethanol, separately. The obtained solutions were mixed together. The mixed solution was then stirred for 24 h, aged at ambient temperature for 24 h, and dried at 80°C in an electrical air oven for 24 h. The prepared powder was finally sintered at 600°C for 2 min in a muffle furnace.<sup><xref ref-type="bibr" rid="bibr25-0021998311426020">25</xref></sup></p>
</sec>
<sec id="sec5-0021998311426020"><title>Preparation of forsterite nanopowder</title>
<p>For this purpose, talc and MgCO<sub>3</sub> powders with molar ratio of 0.2 were mixed by mechanical ball milling underambient conditions in a planetary ball mill using zirconia vial and balls. The ball milling parameters were selected as the follows: ball/powder weight ratio: 10:1, rotational speed: 350 rpm, and time: 10 h. The prepared powder was then heated at 1000°C for 1 h.<sup><xref ref-type="bibr" rid="bibr26-0021998311426020">26</xref></sup></p>
</sec>
<sec id="sec6-0021998311426020"><title>Preparation of BG nanopowder</title>
<p>In this study, 63 S BG with 65% SiO<sub>2</sub>, 31% CaO, and 4% P<sub>2</sub>O<sub>5</sub> in molar percentages were used. The TEOS was dissolved in absolute ethanol and deionized water, by using 2 N HCl as a catalyst, and stirred for 30 min. The TEP was then dissolved into the prepared solution. After 20 min, Ca(NO<sub>3</sub>)<sub>2</sub>·4H<sub>2</sub>O was added. The clear solution was then aged at 60°C for 48 h and dried at 120°C for 48 h. The obtained powder was calcined at 600°C for 2 h.<sup><xref ref-type="bibr" rid="bibr27-0021998311426020">27</xref></sup></p>
</sec>
<sec id="sec7-0021998311426020"><title>Fabrication of composite foam</title>
<p>The same amounts of HA, forsterite, and BG powders were mixed together by ball milling (B/P: 5/1, rotational speed: 175 rpm, and time: 45 min). The obtained powder was dispersed in deionized water by using 1 wt.% TPP as a dispersant. At the same time, agarose powder (7 wt.%) as a gelling agent was dissolved in deionized water by heating up to 130°C. Two solutions were mixed together at 80°C. The prepared slurry by addition of 3 volume percent (vol.%) of Tergitol and vigorous agitation using a triple-blade mixer was foamed and poured into the mold. The gelling reaction was conducted by cooling the samples to 0°C. The samples were then demolded, dried at ambient conditions, and sintered at different temperatures for 4 h.<sup><xref ref-type="bibr" rid="bibr23-0021998311426020">23</xref></sup></p>
</sec>
<sec id="sec8-0021998311426020"><title>Materials characterization</title>
<sec id="sec9-0021998311426020"><title>X-ray diffraction analysis</title>
<p>X-ray diffraction (XRD, Philips Xpert) experiments were performed with a cu kα wavelength of 0.154186 nm at 40 kV and 40 mA, in the range 20° ≤ 2θ ≤ 80°, with a step size of 0.05° and a time per step of 1 s to identified the phases present in the prepared powders and composite foams. The obtained experimental patterns were compared to the standards, compiled by joint committee on powder diffraction and standards (JCDPS).</p>
<p>The crystallite size of the starting powders and sintered foams was determined by broadening of XRD peaks using Scherrer’s equation<sup><xref ref-type="bibr" rid="bibr28-0021998311426020">28</xref></sup>:
<disp-formula id="disp-formula1-0021998311426020"><label>(1)</label><graphic xlink:href="10.1177_0021998311426020-eq1.tif"/></disp-formula>
where <italic>k</italic> is a constant (<italic>k</italic> = 0.89), λ is the wavelength, θ is the diffraction angle, and β is the full-width at half-maximum intensity (rad), and <italic>d</italic> is the average crystallite size.</p>
</sec>
<sec id="sec10-0021998311426020"><title>Electron microscopy analyses</title>
<p>In order to investigate the morphology, size, distribution, and interconnectivity of the pores before and after immersing the composite foam in the SBF, the specimens were coated with a film of gold (Au) using sputtering technique and scanning electron microscopy (SEM) evaluations were performed using a Philips XL 30 that was equipped with energy dispersive spectrometer (EDS) analyzer. Transmission electron microscopy (TEM, Philips CM-200) was used to observe the particle size and shape of the prepared foams.</p>
</sec>
<sec id="sec11-0021998311426020"><title>Porosity measurements</title>
<p>Archimedes method was used in order to characterize the interconnected and total porosity of the composite foams. The measurements were based on an average of three samples of the foams for each sintering temperature. The values of the interconnected (open) and total porosity were determined as shown in Equations (<xref ref-type="disp-formula" rid="disp-formula2-0021998311426020">2</xref>) and (<xref ref-type="disp-formula" rid="disp-formula3-0021998311426020">3</xref>), respectively.
<disp-formula id="disp-formula2-0021998311426020"><label>(2)</label><graphic xlink:href="10.1177_0021998311426020-eq2.tif"/></disp-formula>
<disp-formula id="disp-formula3-0021998311426020"><label>(3)</label><graphic xlink:href="10.1177_0021998311426020-eq3.tif"/></disp-formula>
where ρ is the true density or specific gravity of the ceramic powder, <italic>W<sub>d</sub></italic> is the weight of the dry foam, <italic>W<sub>s</sub></italic> is the weight of the foam when it is suspended in water, and <italic>W<sub>w</sub></italic> is the weight of the foam, when it is removed from the water.</p>
</sec>
<sec id="sec12-0021998311426020"><title>Mechanical characterization</title>
<p>Since the bioceramic foams are very brittle, it is difficult to make the appropriate shape, which is need for mechanical propertiesmeasurement by different machining method. Therefore, a good criterion to characterize the mechanical properties of the bioceramic foams is application of compression test. For this purpose, cylindrical samples (10 mm in diameter and 20 mm in length) were prepared and the compression tests were carried out on an universal testing machine (zwick, material prufung, 1446-60), with a crosshead speed of 0.5 mm/min. The compressive strength was evaluated from the maximum point of the stress/strain graph. The measurements were based on an average of five samples of the foams for each sintering temperature.</p>
</sec>
<sec id="sec13-0021998311426020"><title>In vitro evaluation</title>
<p>The bioactivity and bioresorbability of the prepared composite foams were estimated byimmersing the sintered foams in sterilized bottles containing the appropriate amount (liquid/solid ratio of 0.1 mL/mg) of SBF solution. The SBF was prepared according to Kokubo et al.’s description,<sup><xref ref-type="bibr" rid="bibr29-0021998311426020">29</xref></sup> and the immersion test was performed in a temperature-controlled shaking water bath at 36.5 ± 0.5°C for 28days without refreshing the soaking solution. This method has been widely used to indicate the similarity between in vitro and in vivo behavior of specific compositions. The foams were then removed from the SBF, rinsed with distilled water, and dried at room condition. The changes in pH value of the solutions were measured by a pH meter during this time. The SEM micrographs were used to observe the bone-like apatite formation on the surface of the foams and pores filling by formation of apatite. Fourier transform infrared reaction (FTIR, Bruker Tensor 27) spectroscopy was performed to identify the formation of apatite.</p>
</sec>
</sec>
</sec>
<sec id="sec14-0021998311426020" sec-type="results"><title>Results and discussion</title>
<p><xref ref-type="fig" rid="fig1-0021998311426020">Figure 1</xref> shows XRD spectra for foams sintered at 800,850, 900, 1000, and 1100°C. The spectra of foam sintered at 800°C only showed the peaks corresponding to HA and forsterite.<sup><xref ref-type="bibr" rid="bibr30-0021998311426020">30</xref>,<xref ref-type="bibr" rid="bibr31-0021998311426020">31</xref></sup> However, by increasing the sintering temperature to 850°C, the peaks of beta-tricalcium phosphate (β-TCP) were appeared in the pattern of foam.<sup><xref ref-type="bibr" rid="bibr32-0021998311426020">32</xref></sup> The conversion of HA peaks to β-TCP peaks in <xref ref-type="fig" rid="fig1-0021998311426020">Figure 1</xref>(b) and (c) were indicative of decomposition of HA and BG to β-TCP phase. By further increasing of sintering temperature up to 1000°C, the spectra of foams exhibited the peaks that were indicative of Larnite (Ca<sub>2</sub>SiO<sub>4</sub>).<sup><xref ref-type="bibr" rid="bibr33-0021998311426020">33</xref></sup> These peaks show the crystallization of amorphous BG at high temperatures that will affect its bioactivity and resorbability.<sup><xref ref-type="bibr" rid="bibr34-0021998311426020">34</xref></sup> Fine particles of sol-gel BG will crystallize above 900°C. They will become wollastonite or Ca<sub>2</sub>SiO<sub>4</sub> depending on composition of the BG.<sup><xref ref-type="bibr" rid="bibr34-0021998311426020">34</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr37-0021998311426020">37</xref></sup> Other authors reported this phase transformation. For example, Hench et al. and Saboori et al. reported from the differential thermal analysis (DTA) trace that the glass transition temperature (TG) was 950°C and is attributed to the crystallization of CaSiO<sub>3</sub>.<sup><xref ref-type="bibr" rid="bibr37-0021998311426020">37</xref>,<xref ref-type="bibr" rid="bibr38-0021998311426020">38</xref></sup> Fathi et al. reported that the fine particles of sol-gel BG (belongs to the system CaO-SiO<sub>2</sub>-P<sub>2</sub>O<sub>5</sub> with 57.44% CaO, 35.42% SiO<sub>2</sub>, and 7.15% P<sub>2</sub>O<sub>5</sub> in molar percentages) had kept the amorphous state up to 900°C and were crystallized to Ca<sub>2</sub>SiO<sub>4</sub> phase at approximately 1000°C.<sup><xref ref-type="bibr" rid="bibr37-0021998311426020">37</xref></sup>
<fig id="fig1-0021998311426020" position="float"><label>Figure 1.</label><caption><p>X-ray diffraction (XRD) patterns of the composite foam sintered at (a) 800°C, (b) 850°C, (c) 900°C, (d) 1000°C, and (e)1100°C for 4 h.</p></caption><graphic xlink:href="10.1177_0021998311426020-fig1.tif"/></fig></p>
<p><xref ref-type="fig" rid="fig2-0021998311426020">Figure 2</xref>(a) shows XRD pattern of HA foam sintered at 800°C. This XRD pattern can be completely indexed with HA, the only phase found present.<sup><xref ref-type="bibr" rid="bibr30-0021998311426020">30</xref></sup> <xref ref-type="fig" rid="fig2-0021998311426020">Figure 2</xref>(b) shows XRD pattern of forsterite foam sintered at 1200°C and only exhibits the peaks corresponding to forsterite.<sup><xref ref-type="bibr" rid="bibr31-0021998311426020">31</xref></sup> <xref ref-type="fig" rid="fig2-0021998311426020">Figure 2</xref>(c) shows XRD pattern of composite foam sintered at 1100°C, which illustrated the foam contained HA, forsterite, β-TCP, and Ca<sub>2</sub>SiO<sub>4</sub> phases. Inset in <xref ref-type="fig" rid="fig2-0021998311426020">Figure 2</xref> shows peak broadening indicating the presence of amorphous phases on the composite foam, which were related to the amorphous BG. So the foam sintered at 900°C consists of HA, forsterite, β-TCP, and BG and, since that it has no additional peaks of Ca<sub>2</sub>SiO<sub>4</sub> phase, is appropriate for biomedical application due to its good bioactivity and bioresorbability.
<fig id="fig2-0021998311426020" position="float"><label>Figure 2.</label><caption><p>X-ray diffraction (XRD) patterns of the (a) hydroxyapatite (HA) foam sintered at 800°C, (b) forsterite foam sintered at 1200°C, and (c) composite foam sintered at 1100°C for 4 h. Inset shows peak broadening indicating an amorphous phase on the composite foam.</p></caption><graphic xlink:href="10.1177_0021998311426020-fig2.tif"/></fig></p>
<p>The crystallite size of the composite foams was measured by broadening of XRD peaks using Equation (<xref ref-type="disp-formula" rid="disp-formula1-0021998311426020">1</xref>) in the range 30–52 nm, while the crystallite size of the prepared HA and forsterite powders was measured about 22 nm.</p>
<p><xref ref-type="fig" rid="fig3-0021998311426020">Figure 3</xref> shows the porous structure of the composite foam sintered at 900°C for 4 h. This figure also shows that the foam has an open, interconnected, and uniform porous macrostructure with pore sizes ranged from 100 to 300 µm. The foams or scaffolds are required to reconstruct the bone tissue characteristics not only in terms of composition but also in terms of pore size and morphology. The foams should allow growth of bone and soft tissues within large pores and blood supply for further bone mineralization. There are numerous studies in which the influence of pore size and porosity on the biological behavior of bone graft substitutes has been inspected; however, no consensus has been reached yet with regard to the best pore size. Freyman et al. suggested that the interconnected pore diameter should be greater than 100 µm to allow tissue ingrowth and finally vascularization.<sup><xref ref-type="bibr" rid="bibr38-0021998311426020">38</xref></sup> Hulbert et al. recommended that the optimum pore size for osteoconduction is 150 µm.<sup><xref ref-type="bibr" rid="bibr39-0021998311426020">39</xref></sup> Flatley et al. reported that a pore size in the range 200–500 µm is appropriate for colonization of osteoblast in the pores, fibrovascular ingrowth, and finally the deposition of new bone.<sup><xref ref-type="bibr" rid="bibr40-0021998311426020">40</xref></sup> Mentioned reports illustrated that the pore size and an interconnected pore structure, as the one shown in <xref ref-type="fig" rid="fig3-0021998311426020">Figure 3</xref> are suitable for osteoblasts ingrowth,<sup><xref ref-type="bibr" rid="bibr41-0021998311426020">41</xref></sup> rapid vascularization, and bone reconstructing.<sup><xref ref-type="bibr" rid="bibr42-0021998311426020">42</xref></sup> Rapid vascularization is needed to support the mechanical strength of the foam as it gradually degrades during bone remodeling. Interconnected porous network is also necessary to allows biomolecules and degraded substances to freely flow into and out the foam.<sup><xref ref-type="bibr" rid="bibr43-0021998311426020">43</xref></sup>
<fig id="fig3-0021998311426020" position="float"><label>Figure 3.</label><caption><p>Scanning electron microscopy (SEM) micrographs of the composite foam sintered at 900°C for 4 h.</p></caption><graphic xlink:href="10.1177_0021998311426020-fig3.tif"/></fig></p>
<p>The mean values of total and interconnected porosityof the composite foams were calculated using Equations (<xref ref-type="disp-formula" rid="disp-formula2-0021998311426020">2</xref>) and (<xref ref-type="disp-formula" rid="disp-formula3-0021998311426020">3</xref>) in the range 81–87% and 72–80%, respectively. The value of interconnected porosity is related to properties such as surface area and permeability of the porous structure. Furthermore, the values of total and interconnected porosity of the foam can influence its mechanical strength, permeability, and presence of structural defects.<sup><xref ref-type="bibr" rid="bibr44-0021998311426020">44</xref></sup> High-porosity level signifies a high surface area/volume ratio, and thus favors cell adhesion to the foam and promotes bone tissue regeneration.</p>
<p><xref ref-type="table" rid="table1-0021998311426020">Table 1</xref> summarizes the characterization data of the composite foams at different sintering temperatures, including the total porosity, interconnected porosity, compressive strength, and elastic modulus values. As the sintering temperature was increased, the porosity and pore size decreased, important factors that enhance the mechanical properties of the foam.
<table-wrap id="table1-0021998311426020" position="float"><label>Table 1.</label><caption><p>The total and interconnected porosity, compressive strength, and elastic modulus of the composite foams at different sintering temperatures</p></caption>
<graphic alternate-form-of="table1-0021998311426020" xlink:href="10.1177_0021998311426020-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Sintering temperature</th>
<th>Total porosity (%; SD<sup><xref ref-type="table-fn" rid="table-fn1-0021998311426020">a</xref></sup>)</th>
<th>Interconnected porosity (%; SD)</th>
<th>Compressive strength (MPa; SD)</th>
<th>Elastic modulus (MPa; SD)</th></tr></thead>
<tbody align="left">
<tr>
<td>800°C</td>
<td>87 (±0.9)</td>
<td>80 (±1.8)</td>
<td>2.19 (±0.21)</td>
<td>163 (±17)</td></tr>
<tr>
<td>850°C</td>
<td>86 (±1.1)</td>
<td>78 (±1.3)</td>
<td>2.64 (±0.16)</td>
<td>180 (±14)</td></tr>
<tr>
<td>900°C</td>
<td>84 (±1.4)</td>
<td>75 (±1)</td>
<td>3.15 (±0.07)</td>
<td>197 (±23)</td></tr>
<tr>
<td>1000°C</td>
<td>82 (±0.8)</td>
<td>73 (±0.9)</td>
<td>3.39 (±0.14)</td>
<td>221 (±9)</td></tr>
<tr>
<td>1100°C</td>
<td>81 (±1.2)</td>
<td>72 (±1.1)</td>
<td>3.68 (±0.10)</td>
<td>262 (±12)</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0021998311426020"><label>a</label><p>Standard deviation.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>The elastic modulus and compressive strength of the foams at different sintering temperatures were measuredin the range 163–262 MPa and 2.19–3.68 MPa. These ranges of elastic modulus and compressive strength are within the lower limit of the elastic modulus and compressive strength of trabecular bone, which has an elastic modulus of between 0.05 and 0.5 GPa and compressive strength of between 2 and 12 MPa.<sup><xref ref-type="bibr" rid="bibr45-0021998311426020">45</xref></sup> On the other hand, Gibson and Ashby reported that the compressive strength of spongy bone is in the range of 0.2–4 MPa, when the relative density is close to 0.1.<sup><xref ref-type="bibr" rid="bibr46-0021998311426020">46</xref></sup> Hence, the measured compressive strength (2.19–3.68 MPa) of the present composite foams falls in this range, and lies closer to the upper limit. <xref ref-type="fig" rid="fig4-0021998311426020">Figure 4</xref> is typical example of compressive stress–strain curve for the composite foam. The compressive stress–strain chart shows a typical behavior for elastic–brittle ceramic foams, that is displaying a linear elastic region that followed by subsequent brittle fracture of the struts.<sup><xref ref-type="bibr" rid="bibr47-0021998311426020">47</xref></sup>
<fig id="fig4-0021998311426020" position="float"><label>Figure 4.</label><caption><p>Typical compressive stress–strain curve of the composite foam.</p></caption><graphic xlink:href="10.1177_0021998311426020-fig4.tif"/></fig></p>
<p><xref ref-type="fig" rid="fig5-0021998311426020">Figure 5</xref> shows the TEM micrograph of the sintered composite foam at 900°C for 4 h. These micrographs show that the foam is formed by nanosized ellipse-likegrains with a size smaller than 100 nm. This is in agreement with the crystallite size of the composite foams calculated using XRD data. It was illustrated that nanosized bioceramics have superior biological and mechanical properties and higher dissolution rate than that of microsized bioceramics, and thus apatite is formed more easily.<sup><xref ref-type="bibr" rid="bibr47-0021998311426020">47</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr49-0021998311426020">49</xref></sup> Nanosized characteristic of prepared foam renders it similar to natural bone and so increase the biocompatibility and biological behaviors of the foam.
<fig id="fig5-0021998311426020" position="float"><label>Figure 5.</label><caption><p>Transmission electron microscopy (TEM) micrograph of the composite foam sintered at 900°C for 4 h.</p></caption><graphic xlink:href="10.1177_0021998311426020-fig5.tif"/></fig></p>
<p>The formation of an apatite-like layer over the composite foam surface after immersion in SBF was taken as an index of the in vitro bioactivity. The samples were extracted from the SBF solution after 28 days, rinsed softly using deionized water, and left to dry at ambient temperature. <xref ref-type="fig" rid="fig6-0021998311426020">Figure 6</xref> shows the surface of the composite foam sintered at 900°C for 4 h after 28 days of immersion in SBF. It can be observed that the surface of the foam was covered with a new layer (spherical white particles) after soaking them in SBF, which was identified as apatite by FTIR and EDS.<sup><xref ref-type="bibr" rid="bibr23-0021998311426020">23</xref>,<xref ref-type="bibr" rid="bibr24-0021998311426020">24</xref>,<xref ref-type="bibr" rid="bibr47-0021998311426020">47</xref></sup>
<fig id="fig6-0021998311426020" position="float"><label>Figure 6.</label><caption><p>Scanning electron microscopy (SEM) micrographs of the composite foam sintered at 900°C for 4 h after 28 days of immersion in simulated body fluid (SBF).</p></caption><graphic xlink:href="10.1177_0021998311426020-fig6.tif"/></fig></p>
<p><xref ref-type="fig" rid="fig7-0021998311426020">Figure 7</xref> shows a graph of the changes of pH vs. time that demonstrates the degradability of composite foam. The graph also shows the variation of pH vs. time for HA and forsterite foams for comparison. Since, the graph of pH trend clarify the dissolution or bioresorbability behavior of the soaking samples, thus the composite foam have more solubility in comparison to HA and forsterite foams. It causes to more exchange of Na<sup>+</sup>, Ca<sup>2+</sup>, and Mg<sup>2+</sup> with H<sup>+</sup> or H<sub>3</sub>O<sup>+</sup> from solution and so further increasing of the pH of solution. All of the graphs firstly show linear increasing region due to the exchange of cations with H<sup>+</sup> or H<sub>3</sub>O<sup>+</sup> from SBF, and then gradually decrease of pH due to consuming OH<sup>-</sup> ions in the formation of an apatite-like layer.
<fig id="fig7-0021998311426020" position="float"><label>Figure 7.</label><caption><p>The graphs of the pH trends for the hydroxyapatite (HA), forsterite, and composite foams as a function of soaking time.</p></caption><graphic xlink:href="10.1177_0021998311426020-fig7.tif"/></fig></p>
<p>The prepared composite foam, because of its highly porous structure (up to 87%) and excellent mechanical properties, is appropriate for load-bearing biomedical application. Its strength is sufficient for the foam to be manipulated adequately, such as cutting of the foam for compressive strength measurements and manipulating during SBF tests. In addition, it has been demonstrated that the compressive strength of a porous scaffold such as porous HA significantly increases due to tissue ingrowth in vivo,<sup><xref ref-type="bibr" rid="bibr50-0021998311426020">50</xref></sup> so it is not necessary to fabricate a foam with a mechanical strength equal to bone. Since it is very important that the foam remains bioactive when treated at the sintering temperature; the optimal sintering temperature in this study was specified about 900°C for 4 h, because there is not any Ca<sub>2</sub>SiO<sub>4</sub> phase in this sintering temperature to decrease the bioactivity and bioresorbability of the foam. Therefore, the importance of an ideal scaffold is to supply sufficient mechanical support temporarily and can biodegrade later at a sufficient rate is achievable with the prepared composite foam.</p>
<p>Further study will be focused on optimizing the ratio of BG phase to ceramic phases for achieving appropriate mechanical strength, bioactivity, and biodegradability.</p>
</sec>
<sec id="sec15-0021998311426020" sec-type="conclusions"><title>Conclusions</title>
<p>In this work, highly porous, mechanically competent, bioactive, and bioresorbable triple nanobioceramic composite foam consisting of HA, BG, and forsterite has been successfully synthesized for tissue engineering, using the gelcasting technique. The prepared foams have total and interconnected porosity up to 87% and 81%, respectively. The grain size of the prepared foams was recognized smaller than 100 nm and the pore size was observed in the range 100–300 µm. The crystallite size ofthe composite foams was measured in the range 30–52 nm, while the crystallite size of the initial powders was about 22 nm. The compressive strength measurements showed that the foams have an excellent compressive strength (2.19–3.68 MPa), which is appropriate fortissue engineering applications and is close to the compressive strength of spongy bone. The resulting composite foams have good bioactivity and resorbability and similar chemical composition to the mineral phase of bone and it is possible to optimize the ratioof BG phase to ceramic phases for achieving appropriate mechanical strength, bioactivity, and biodegradability level needed for different applications. The obtained results were considered satisfactory by the authors for applying the manufactured composite foams for tissue engineering applications such as drug delivery and cell loading, but cell culture and in vivo tests are needed for more assurance.</p>
</sec>
</body>
<back>
<ack><title>Acknowledgment</title>
<p>The authors are grateful for support of this research by Isfahan University of Technology.</p></ack>
<ref-list>
<title>References</title>
<ref id="bibr1-0021998311426020"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Polak</surname><given-names>JM</given-names></name></person-group>. <article-title>Third generation biomaterials</article-title>. <source>Science</source> <year>2002</year>; <volume>295</volume>: <fpage>1014</fpage>–<lpage>1017</lpage>.</citation></ref>
<ref id="bibr2-0021998311426020"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Gentleman</surname><given-names>E</given-names></name><name><surname>Polak</surname><given-names>J</given-names></name></person-group>. <article-title>Bioactive glass scaffolds for bone regeneration</article-title>. <source>Elements</source> <year>2007</year>; <volume>3</volume>: <fpage>393</fpage>–<lpage>399</lpage>.</citation></ref>
<ref id="bibr3-0021998311426020"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirtliff</surname><given-names>VJ</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioactive materials for tissue engineering, regeneration and repair</article-title>. <source>J Mater Sci</source> <year>2003</year>; <volume>38</volume>(<issue>23</issue>): <fpage>4697</fpage>–<lpage>4707</lpage>.</citation></ref>
<ref id="bibr4-0021998311426020"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaahtio</surname><given-names>M</given-names></name><name><surname>Peltola</surname><given-names>T</given-names></name><name><surname>Hentunen</surname><given-names>T</given-names></name><name><surname>Ylanen</surname><given-names>H</given-names></name><name><surname>Areva</surname><given-names>S</given-names></name><name><surname>Wolke</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The properties of biomimetically processed calcium phosphate on bioactive ceramics and their response on bone cells</article-title>. <source>J Mater Sci Mate Med</source> <year>2006</year>; <volume>17</volume>: <fpage>1113</fpage>–<lpage>1125</lpage>.</citation></ref>
<ref id="bibr5-0021998311426020"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>GK</given-names></name><name><surname>Goldberg</surname><given-names>HA</given-names></name></person-group>. <article-title>Nucleation of hydroxyapatite by bone sialoprotein</article-title>. <source>Proc Nut Acad Sci USA</source> <year>1993</year>; <volume>90</volume>: <fpage>8562</fpage>–<lpage>8565</lpage>.</citation></ref>
<ref id="bibr6-0021998311426020"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ripamonti</surname><given-names>U</given-names></name><name><surname>Crooks</surname><given-names>J</given-names></name><name><surname>Kirkbride</surname><given-names>AN</given-names></name></person-group>. <article-title>Sintered porous hydroxyapatites with intrinsic osteoinductive activity: geometric induction of bone formation</article-title>. <source>S Afr J Sci</source> <year>1999</year>; <volume>95</volume>: <fpage>335</fpage>–<lpage>343</lpage>.</citation></ref>
<ref id="bibr7-0021998311426020"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioceramics</article-title>. <source>J Am Ceram Soc</source> <year>1998</year>; <volume>81</volume>(<issue>7</issue>): <fpage>1705</fpage>–<lpage>1728</lpage>.</citation></ref>
<ref id="bibr8-0021998311426020"><label>8</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>LeGeros</surname><given-names>RZ</given-names></name><name><surname>LeGeros</surname><given-names>JP</given-names></name></person-group>. In: <person-group person-group-type="editor"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name></person-group> (eds) <source>An introduction to bioceramics</source>, <edition>2nd ed</edition>. <publisher-loc>London</publisher-loc>: <publisher-name>Word Scientific</publisher-name>, <year>1999</year>, pp. <fpage>139</fpage>–<lpage>180</lpage>.</citation></ref>
<ref id="bibr9-0021998311426020"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioactive materials</article-title>. <source>Ceram Int</source> <year>1996</year>; <volume>22</volume>: <fpage>493</fpage>–<lpage>507</lpage>.</citation></ref>
<ref id="bibr10-0021998311426020"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tancred</surname><given-names>DC</given-names></name><name><surname>Carr</surname><given-names>AJ</given-names></name><name><surname>Mccormack</surname><given-names>BAO</given-names></name></person-group>. <article-title>Development of a new synthetic bone graft</article-title>. <source>J Mater Sci: Mater Med</source> <year>1998</year>; <volume>9</volume>: <fpage>819</fpage>–<lpage>823</lpage>.</citation></ref>
<ref id="bibr11-0021998311426020"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Hariram</surname><given-names>KP</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Cheang</surname><given-names>P</given-names></name><name><surname>Aik</surname><given-names>KK</given-names></name></person-group>. <article-title>In vitro apatite formation and its growth kinetics on hydroxyapatite/polyetheretherketone biocomposites</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>2343</fpage>–<lpage>2352</lpage>.</citation></ref>
<ref id="bibr12-0021998311426020"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Fartash</surname><given-names>B</given-names></name><name><surname>Hermansson</surname><given-names>L</given-names></name></person-group>. <article-title>High strength ceramics with potential bioactivity</article-title>. <source>Interceram</source> <year>1990</year>; <volume>39</volume>: <fpage>20</fpage>–<lpage>23</lpage>.</citation></ref>
<ref id="bibr13-0021998311426020"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>S</given-names></name><name><surname>Champion</surname><given-names>E</given-names></name><name><surname>Bernache-Assolant</surname><given-names>D</given-names></name></person-group>. <article-title>Processing, microstructure and toughness of Al<sub>2</sub>O<sub>3</sub> platelet-reinforced hydroxyapatite</article-title>. <source>J Eur Ceram Soc</source> <year>1997</year>; <volume>17</volume>: <fpage>1361</fpage>–<lpage>1369</lpage>.</citation></ref>
<ref id="bibr14-0021998311426020"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knowles</surname><given-names>JC</given-names></name></person-group>. <article-title>Development of hydroxyapatite with enhanced mechanical properties-effect of high glass additions on mechanical properties and phase stability of sintered hydroxyapatite</article-title>. <source>Br Ceram Trans</source> <year>1994</year>; <volume>93</volume>: <fpage>100</fpage>–<lpage>103</lpage>.</citation></ref>
<ref id="bibr15-0021998311426020"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruys</surname><given-names>AJ</given-names></name><name><surname>Ehsani</surname><given-names>GN</given-names></name><name><surname>Milthorpe</surname><given-names>BK</given-names></name><name><surname>Sorrell</surname><given-names>CC</given-names></name></person-group>. <article-title>Effects of nonoxied additions on the decomposition andsintering of hydroxyapatite</article-title>. <source>J Aust Ceram Soc</source> <year>1993</year>; <volume>29</volume>: <fpage>65</fpage>–<lpage>69</lpage>.</citation></ref>
<ref id="bibr16-0021998311426020"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name></person-group>. <article-title>Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics</article-title>. <source>J Biomed Mater Res B: Appl Biomater</source> <year>2007</year>; <volume>83</volume>(<issue>1</issue>): <fpage>153</fpage>–<lpage>160</lpage>.</citation></ref>
<ref id="bibr17-0021998311426020"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miake</surname><given-names>Y</given-names></name><name><surname>Yanagisawa</surname><given-names>T</given-names></name><name><surname>Yajima</surname><given-names>Y</given-names></name><name><surname>Noma</surname><given-names>H</given-names></name><name><surname>Yasui</surname><given-names>N</given-names></name><name><surname>Nonami</surname><given-names>T</given-names></name></person-group>. <article-title>High-resolution and analytical electron microscopic studies of new crystals induced by a bioactive ceramic (diopside)</article-title>. <source>J Dent Res</source> <year>1995</year>; <volume>74</volume>(<issue>11</issue>): <fpage>1756</fpage>–<lpage>1763</lpage>.</citation></ref>
<ref id="bibr18-0021998311426020"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nonami</surname><given-names>T</given-names></name><name><surname>Tsutsumi</surname><given-names>S</given-names></name></person-group>. <article-title>Study of diopside ceramics for biomaterials</article-title>. <source>J Mater Sci</source> <year>1999</year>; <volume>10</volume>(<issue>8</issue>): <fpage>475</fpage>–<lpage>479</lpage>.</citation></ref>
<ref id="bibr19-0021998311426020"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>K</given-names></name><name><surname>Kuroda</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name></person-group>. <article-title>Osteogenic cell cytotoxicity and biomechanical strength of the new ceramic diopside</article-title>. <source>J Biomed Mater Res</source> <year>1997</year>; <volume>37</volume>(<issue>1</issue>): <fpage>100</fpage>–<lpage>107</lpage>.</citation></ref>
<ref id="bibr20-0021998311426020"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>S</given-names></name><name><surname>Chou</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name></person-group>. <article-title>Preparation and characterization of forsterite (Mg<sub>2</sub>SiO<sub>4</sub>) bioceramics</article-title>. <source>Ceram Int</source> <year>2007</year>; <volume>33</volume>: <fpage>83</fpage>–<lpage>88</lpage>.</citation></ref>
<ref id="bibr21-0021998311426020"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name></person-group>. <article-title>Surface-active biomaterials</article-title>. <source>Science</source> <year>1984</year>; <volume>226</volume>: <fpage>630</fpage>–<lpage>636</lpage>.</citation></ref>
<ref id="bibr22-0021998311426020"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Splinter</surname><given-names>RJ</given-names></name><name><surname>Allen</surname><given-names>WC</given-names></name><name><surname>Greenlee</surname><given-names>TK</given-names></name></person-group>. <article-title>Bonding mechanisms at the interface of ceramic prosthetic materials</article-title>. <source>J Biomed Mater Res</source> <year>1972</year>; <volume>2</volume>(<issue>1</issue>): <fpage>117</fpage>–<lpage>141</lpage>.</citation></ref>
<ref id="bibr23-0021998311426020"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghomi</surname><given-names>H</given-names></name><name><surname>Jaberzadeh</surname><given-names>M</given-names></name><name><surname>Fathi</surname><given-names>MH</given-names></name></person-group>. <article-title>Novel fabrication of forsterite scaffold with improved mechanical properties</article-title>. <source>J Alloys Compd</source> <year>2011</year>; <volume>509</volume>: <fpage>63</fpage>–<lpage>68</lpage>.</citation></ref>
<ref id="bibr24-0021998311426020"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghomi</surname><given-names>H</given-names></name><name><surname>Fathi</surname><given-names>MH</given-names></name><name><surname>Edris</surname><given-names>H</given-names></name></person-group>. <article-title>Preparation of nanostructure hydroxyapatite scaffold for tissue engineering applications</article-title>. <source>J Sol-Gel Sci Technol</source> <year>2011</year>; <volume>58</volume>: <fpage>642</fpage>–<lpage>650</lpage>.</citation></ref>
<ref id="bibr25-0021998311426020"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fathi</surname><given-names>MH</given-names></name><name><surname>Hanifi</surname><given-names>A</given-names></name></person-group>. <article-title>Evaluation and characterization of nanostructure hydroxyapatite powder prepared by simple sol-gel method</article-title>. <source>Mater Lett</source> <year>2007</year>; <volume>61</volume>: <fpage>3978</fpage>–<lpage>3983</lpage>.</citation></ref>
<ref id="bibr26-0021998311426020"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tavangarian</surname><given-names>F</given-names></name><name><surname>Emadi</surname><given-names>R</given-names></name></person-group>. <article-title>Mechanical activation assisted synthesis of pure nanocrystalline forsterite powder</article-title>. <source>JAlloys Compd</source> <year>2009</year>; <volume>485</volume>: <fpage>648</fpage>–<lpage>652</lpage>.</citation></ref>
<ref id="bibr27-0021998311426020"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>V</given-names></name><name><surname>Mehdikhani Nahrkhalaji</surname><given-names>M</given-names></name><name><surname>Fathi</surname><given-names>MH</given-names></name><name><surname>Mousavi</surname><given-names>SB</given-names></name><name><surname>Nasr Esfahani</surname><given-names>B</given-names></name></person-group>. <article-title>Antibacterial effects of sol-gel-derived bioactive glass nanoparticle on aerobic bacteria</article-title>. <source>J Biomed Mater Res A</source> <year>2010</year>; <volume>94</volume>: <fpage>160</fpage>–<lpage>168</lpage>.</citation></ref>
<ref id="bibr28-0021998311426020"><label>28</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Cullity</surname><given-names>BD</given-names></name></person-group>. <source>Elements of X-Ray diffraction</source>, <edition>2nd ed</edition>. <publisher-loc>US</publisher-loc>: <publisher-name>Addison-Wesley</publisher-name>, <year>1978</year>.</citation></ref>
<ref id="bibr29-0021998311426020"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kokubo</surname><given-names>T</given-names></name><name><surname>Takadama</surname><given-names>H</given-names></name></person-group>. <article-title>How useful is SBF in predicting in vivo bone bioactivity?</article-title>. <source>Biomater</source> <year>2006</year>; <volume>27</volume>: <fpage>2907</fpage>–<lpage>2915</lpage>.</citation></ref>
<ref id="bibr30-0021998311426020"><label>30</label><citation citation-type="other"><comment>XRD JCPDS data file No.09-0432</comment>.</citation></ref>
<ref id="bibr31-0021998311426020"><label>31</label><citation citation-type="other"><comment>XRD JCPDS data file No.34-0189</comment>.</citation></ref>
<ref id="bibr32-0021998311426020"><label>32</label><citation citation-type="other"><comment>XRD JCPDS data file No.02-0786</comment>.</citation></ref>
<ref id="bibr33-0021998311426020"><label>33</label><citation citation-type="other"><comment>XRD JCPDS data file No.20-0237</comment>.</citation></ref>
<ref id="bibr34-0021998311426020"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atwood</surname><given-names>RC</given-names></name><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>PD</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Analysis of pore interconnectivity in bioactive glass foams using X-ray microtomography</article-title>. <source>Scripta Mater</source> <year>2004</year>; <volume>51</volume>: <fpage>1029</fpage>–<lpage>1033</lpage>.</citation></ref>
<ref id="bibr35-0021998311426020"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saravanapavan</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Pryce</surname><given-names>RS</given-names></name><name><surname>Hench</surname><given-names>LL</given-names></name></person-group>. <article-title>Bioactivity of gel-glass powders in the CaO-SiO<sub>2</sub> system: a comparison with ternary (CaO-P<sub>2</sub>O<sub>5</sub>-SiO<sub>2</sub>) and quaternary glasses (SiO<sub>2</sub>-CaO-P<sub>2</sub>O<sub>5</sub>-Na<sub>2</sub>O)</article-title>. <source>J Biomed Mater Res</source> <year>2003</year>; <volume>66</volume>: <fpage>110</fpage>–<lpage>119</lpage>.</citation></ref>
<ref id="bibr36-0021998311426020"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saboori</surname><given-names>A</given-names></name><name><surname>Rabiee</surname><given-names>M</given-names></name><name><surname>Moztarzadeh</surname><given-names>F</given-names></name><name><surname>Sheikhi</surname><given-names>M</given-names></name><name><surname>Tahriri</surname><given-names>M</given-names></name><name><surname>Karimi</surname><given-names>M</given-names></name></person-group>. <article-title>Synthesis, characterization and in vitro bioactivity of sol-gel-derived SiO<sub>2</sub>-CaO-P<sub>2</sub>O<sub>5</sub>-MgO bioglass</article-title>. <source>Mater Sci Eng C</source> <year>2009</year>; <volume>29</volume>: <fpage>335</fpage>–<lpage>340</lpage>.</citation></ref>
<ref id="bibr37-0021998311426020"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fathi</surname><given-names>MH</given-names></name><name><surname>Doost Mohammadi</surname><given-names>A</given-names></name></person-group>. <article-title>Preparation and characterization of sol-gel bioactive glass coating for improvement of biocompatibility of human body implant</article-title>. <source>Mater Sci Eng A</source> <year>2008</year>; <volume>474</volume>: <fpage>128</fpage>–<lpage>133</lpage>.</citation></ref>
<ref id="bibr38-0021998311426020"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freyman</surname><given-names>TM</given-names></name><name><surname>Yannas</surname><given-names>IV</given-names></name><name><surname>Gibson</surname><given-names>L</given-names></name></person-group>. <article-title>Cellular materials as porous scaffolds for tissue engineering</article-title>. <source>J Prog Mater Sci</source> <year>2001</year>; <volume>46</volume>: <fpage>273</fpage>–<lpage>282</lpage>.</citation></ref>
<ref id="bibr39-0021998311426020"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hulbert</surname><given-names>SF</given-names></name><name><surname>Morrison</surname><given-names>JS</given-names></name><name><surname>Klawitter</surname><given-names>JJ</given-names></name></person-group>. <article-title>Tissue reaction to three ceramics of porous and non porous structures</article-title>. <source>J Biomed Mater Res</source> <year>1972</year>; <volume>6</volume>: <fpage>347</fpage>–<lpage>374</lpage>.</citation></ref>
<ref id="bibr40-0021998311426020"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flatley</surname><given-names>TJ</given-names></name><name><surname>Lynch</surname><given-names>KL</given-names></name><name><surname>Benson</surname><given-names>M</given-names></name></person-group>. <article-title>Tissue response to implants of calcium phosphate ceramic in the rabbit spine</article-title>. <source>Clin Orthop</source> <year>1983</year>; <volume>179</volume>: <fpage>246</fpage>–<lpage>252</lpage>.</citation></ref>
<ref id="bibr41-0021998311426020"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joschek</surname><given-names>S</given-names></name><name><surname>Nies</surname><given-names>B</given-names></name><name><surname>Krotz</surname><given-names>R</given-names></name><name><surname>Gopferich</surname><given-names>A</given-names></name></person-group>. <article-title>Chemical and physiochemical characterization of porous hydroxyapatite ceramics made of natural bone</article-title>. <source>Biomater</source> <year>2000</year>; <volume>21</volume>: <fpage>1645</fpage>–<lpage>1658</lpage>.</citation></ref>
<ref id="bibr42-0021998311426020"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>BS</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><name><surname>Hong</surname><given-names>KS</given-names></name><name><surname>Youn</surname><given-names>HJ</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Chung</surname><given-names>SS</given-names></name><etal/></person-group>. <article-title>Osteoconduction at porous hydroxyapatite with various pore configurations</article-title>. <source>Biomater</source> <year>2000</year>; <volume>21</volume>: <fpage>1291</fpage>–<lpage>1298</lpage>.</citation></ref>
<ref id="bibr43-0021998311426020"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sepulveda</surname><given-names>P</given-names></name><name><surname>Ortega</surname><given-names>FS</given-names></name><name><surname>Innocentini</surname><given-names>MDM</given-names></name><name><surname>Pandolfelli</surname><given-names>VC</given-names></name></person-group>. <article-title>Properties of highly porous hydroxyapatite obtained by the gelcasting of foams</article-title>. <source>J Am Ceram Soc</source> <year>2000</year>; <volume>83</volume>: <fpage>3021</fpage>–<lpage>3024</lpage>.</citation></ref>
<ref id="bibr44-0021998311426020"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>DR</given-names></name><name><surname>Hayes</surname><given-names>WC</given-names></name></person-group>. <article-title>Bone compressive strength: the influence of density and strain rate</article-title>. <source>Science</source> <year>1976</year>; <volume>194</volume>: <fpage>1174</fpage>–<lpage>1176</lpage>.</citation></ref>
<ref id="bibr45-0021998311426020"><label>45</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>LJ</given-names></name><name><surname>Ashby</surname><given-names>MF</given-names></name></person-group>. <source>Cellular solids: structure and properties</source>, <edition>2nd ed</edition>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Pergamon</publisher-name>, <year>1999</year>, pp. <fpage>429</fpage>–<lpage>452</lpage>.</citation></ref>
<ref id="bibr46-0021998311426020"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>DM</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Crawford</surname><given-names>R</given-names></name></person-group>. <article-title>Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly(lactid-co-glycolic acid)</article-title>. <source>Acta Biomater</source> <year>2008</year>; <volume>4</volume>: <fpage>638</fpage>–<lpage>645</lpage>.</citation></ref>
<ref id="bibr47-0021998311426020"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kharaziha</surname><given-names>M</given-names></name><name><surname>Fathi</surname><given-names>MH</given-names></name></person-group>. <article-title>Synthesis and characterization of bioactive forsterite nanopowder</article-title>. <source>Ceram Int</source> <year>2009</year>; <volume>35</volume>: <fpage>2449</fpage>–<lpage>2454</lpage>.</citation></ref>
<ref id="bibr48-0021998311426020"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fathi</surname><given-names>MH</given-names></name><name><surname>Hanifi</surname><given-names>A</given-names></name></person-group>. <article-title>Evaluation and characterization of nanostructure hydroxyapatite powder prepared by simple sol-gel method</article-title>. <source>Mater Lett</source> <year>2007</year>; <volume>67</volume>: <fpage>3978</fpage>–<lpage>3983</lpage>.</citation></ref>
<ref id="bibr49-0021998311426020"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kharaziha</surname><given-names>M</given-names></name><name><surname>Fathi</surname><given-names>MH</given-names></name></person-group>. <article-title>Two-step sintering of dense, nanostructural forsterite</article-title>. <source>Mater Lett</source> <year>2009</year>; <volume>63</volume>: <fpage>1455</fpage>–<lpage>58</lpage>.</citation></ref>
<ref id="bibr50-0021998311426020"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamai</surname><given-names>N</given-names></name><name><surname>Myoui</surname><given-names>A</given-names></name><name><surname>Tomita</surname><given-names>T</given-names></name><name><surname>Nakase</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>J</given-names></name><name><surname>Ochi</surname><given-names>T</given-names></name></person-group>. <article-title>Novel hydroxyapatite ceramics with an interconnective porous structure inhibit superior osteoconduction in vivo</article-title>. <source>J Biomed Mater Res</source> <year>2002</year>; <volume>59</volume>: <fpage>110</fpage>–<lpage>117</lpage>.</citation></ref>
</ref-list>
</back>
</article>